PTPN22 and rheumatoid arthritis: We also found that the presence of anti-CCP antibodies was significantly associated with carriage of the T variant and there was a greatly increased relative risk for the development of RA in individuals with a combination of the PTPN22 1858T variant and anti-CCP antibodies.